New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa™ Genomics, LLC, a clinical laboratory established as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics Inc., today announced the launch of Aventa FusionPlus, a next-genera
World medicine November 09,2023
Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa™ Genomics, LLC, a clinical laboratory established as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics Inc., today announced the launch of Aventa FusionPlus, a next-genera
World medicine November 09,2023
Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

A study published in the journalChildrenaddresses the risk factors associated with the use of social media among adolescents and its impact on their overall wellbeing.Study:Healthy S
World medicine November 09,2023
Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

A study published in the journalChildrenaddresses the risk factors associated with the use of social media among adolescents and its impact on their overall wellbeing.Study:Healthy S
World medicine November 09,2023
Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in
World medicine November 09,2023
Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in
World medicine November 09,2023
Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early dete
World medicine November 09,2023
Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early dete
World medicine November 09,2023
Walkable neighborhoods reduce risk of obesity-related cancers in women

Walkable neighborhoods reduce risk of obesity-related cancers in women

Residing in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer,
World medicine November 09,2023
Walkable neighborhoods reduce risk of obesity-related cancers in women

Walkable neighborhoods reduce risk of obesity-related cancers in women

Residing in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer,
World medicine November 09,2023
Cancer tumors hijack genetic program of developing nerves, study shows

Cancer tumors hijack genetic program of developing nerves, study shows

Cancer tumors "hijack" the genetic program used by developing nerves. This is shown in a study by researchers at Umeå University, Sweden. In the long term, the results may open up new ways o
World medicine November 09,2023
Cancer tumors hijack genetic program of developing nerves, study shows

Cancer tumors hijack genetic program of developing nerves, study shows

Cancer tumors "hijack" the genetic program used by developing nerves. This is shown in a study by researchers at Umeå University, Sweden. In the long term, the results may open up new ways o
World medicine November 09,2023
New method can help researchers map pancreatic cancer development

New method can help researchers map pancreatic cancer development

Pancreatic cancer is one of the deadliest forms of cancer. This is largely due to the cancer being detected at a late stage. In addition, treatment options for pancreatic cancer are limited.Therefore,
World medicine November 09,2023
New method can help researchers map pancreatic cancer development

New method can help researchers map pancreatic cancer development

Pancreatic cancer is one of the deadliest forms of cancer. This is largely due to the cancer being detected at a late stage. In addition, treatment options for pancreatic cancer are limited.Therefore,
World medicine November 09,2023
New robotic breast examination device could help diagnose cancer earlier and save lives

New robotic breast examination device could help diagnose cancer earlier and save lives

A device has been created that could carry out Clinical Breast Examinations (CBE).The manipulator, designed by a team at the University of Bristol and based at the Bristol Robotics Laboratory, is able
World medicine November 09,2023
New robotic breast examination device could help diagnose cancer earlier and save lives

New robotic breast examination device could help diagnose cancer earlier and save lives

A device has been created that could carry out Clinical Breast Examinations (CBE).The manipulator, designed by a team at the University of Bristol and based at the Bristol Robotics Laboratory, is able
World medicine November 09,2023
Breakthrough study shows immunotherapy can help prevent bladder cancer recurrence

Breakthrough study shows immunotherapy can help prevent bladder cancer recurrence

The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual prim
World medicine November 09,2023
Breakthrough study shows immunotherapy can help prevent bladder cancer recurrence

Breakthrough study shows immunotherapy can help prevent bladder cancer recurrence

The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual prim
World medicine November 09,2023
Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

A recentNature Reviews Immunologystudy discusses challenges associated with the development and design of neoantigen cancer vaccines.Study:Challenges in developing personalized
World medicine November 09,2023
Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

A recentNature Reviews Immunologystudy discusses challenges associated with the development and design of neoantigen cancer vaccines.Study:Challenges in developing personalized
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com